Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis

Effect of Natriuretic Peptide–Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction

(2017) G. Michael Felker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

How confidence intervals become confusion intervals

(2013) James McCormack et al.   BMC Medical Research Methodology

2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary

(2013) Clyde W. Yancy et al.   CIRCULATION

Minimal dose for effective clinical outcome and predictive factors for responsiveness to carvedilol: Japanese chronic heart failure (J-CHF) study

(2012) Hiroshi Okamoto et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

(2009) Marvin A Konstam et al.   LANCET

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

(2009) Alessandro Liberati et al.   PLOS MEDICINE

The effects of angiotensin-receptor blockers on mortality and morbidity in heart failure: a systematic review

(2008) M. C. Shibata et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE